查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609026

代謝體學市場：按產品/服務、適應症、應用、最終用戶分類 - 2025-2030 年全球預測

Metabolomics Market by Product & Service (Bioinformatics Tools & Services, Metabolomics Instruments), Indication (Cancer, Cardiovascular Disorders, Inborn Errors of Metabolism), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測，2023年代謝體學市值為37.4億美元，預計到2024年將達到42.8億美元，複合年成長率為15.06%，到2030年將達到99.9億美元。

代謝體學是生物樣本內代謝物的綜合研究，是理解生物體複雜的生化過程的重要工具。該領域對於個人化醫療、疾病生物標記發現和系統生物學的進步至關重要。其應用領域廣泛，包括製藥、生物技術、農業基因組學、食品和飲料等，使其成為健康和營養創新的重要資產。影響調查方法發展的關鍵因素包括分析方法的技術進步、製藥和生物技術研發投資的增加以及需要增強診斷方法的慢性病盛行率的上升。質譜和核磁共振的最新技術創新，加上生物資訊學的進步，為早期疾病檢測和精準醫學的發展提供了重要機會。然而，設備高成本和對熟練人員的需求等挑戰可能會阻礙市場成長。也迫切需要方法和資料解釋的標準化，以彌合複雜資料輸出和實際應用之間的差距。儘管有這些擔憂，北美和歐洲等地區由於其支持性法律規範和高醫療保健支出，在代謝體學創新方面仍處於領先地位。為了利用這個不斷成長的市場，企業應專注於擴大學術機構和產業相關人員之間的合作網路，以促進技術開發和知識交流。此外，開發具有成本效益的高通量篩檢方法有可能改變各行業代謝物分析的可及性和應用。微生物代謝體學、植物代謝體學和環境代謝體學等新領域的探索有可能帶來新產品的開發和多樣化。代謝體學市場不斷發展的性質為研究和創新提供了肥沃的土壤，公司正在利用技術進步，您需要緊跟政策變化。

主要市場統計
基準年[2023] 37.4億美元
預計年份 [2024] 42.8億美元
預測年份 [2030] 99.9億美元
複合年成長率（%） 15.06%

市場動態：揭示快速發展的代謝體學市場的關鍵市場洞察

供給和需求的動態交互作用正在改變代謝體學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 癌症患者數量的增加和對先進治療的需求
    • 繼續推出個人化醫療
    • 政府積極進行相關研究工作
  • 市場限制因素
    • 對複雜資料監控和資料的擔憂
  • 市場機會
    • 代謝體學市場參與企業新技術的出現
    • 單細胞代謝體學的興起
  • 市場挑戰
    • 全球醫療保健領域缺乏熟練的專業人員

波特的五力：駕馭代謝代謝體學市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解代謝體學市場的外部影響

外部宏觀環境因素在塑造代謝體學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解代謝體學市場的競爭格局

代謝體學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣代謝體學市場供應商績效評估

FPNV定位矩陣是評估代謝體學市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了代謝體學市場的成功之路

代謝體學市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症病例的盛行率和先進治療的需要
      • 繼續推出個人化醫療
      • 與代謝體學研究相關的首選政府舉措
    • 抑制因素
      • 對複雜資料監控和資料的擔憂
    • 機會
      • 代謝體學市場參與者與新技術的出現
      • 單細胞代謝體學的興起
    • 任務
      • 全球醫療保健領域缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章代謝體學市場：依產品與服務

  • 生物資訊學工具和服務
    • 生物資訊服務
    • 生物資訊工具和資料庫
  • 代謝體學儀器
    • 檢測工具
      • 質譜分析
      • 核磁共振波譜
      • 基於表面的質譜分析
    • 分離工具
      • 毛細管電泳
      • 氣相層析法
      • 高效液相層析
      • 超高效液相層析

第7章依適應症分類的代謝體學市場

  • 癌症
  • 心血管疾病
  • 先天性代謝異常
  • 代謝紊亂
  • 神經系統疾病

第8章代謝體學市場：依應用分類

  • 生物標記發現
  • 藥物發現
  • 功能基因體學
  • 營養基因體學
  • 個人化醫療
  • 毒性試驗

第 9 章代謝體學市場：依最終使用者分類

  • 學術研究所
  • 合約調查機構
  • 製藥和生物技術公司

第10章美洲代謝體學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區代謝體學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的代謝體學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Afekta Technologies Ltd.
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Science AG
  • Bruker Corporation
  • Danaher Corporation
  • General Electric Company
  • Hitachi High-Tech Corporation
  • Human Metabolome Technologies America Inc.
  • Japan Spectroscopic Company
  • Kore Technology Limited
  • LECO Corporation
  • Merck KGaA
  • SCION Instruments UK Ltd
  • Shimadzu Corporation
  • Waters Corporation
Product Code: MRR-50124643847C

The Metabolomics Market was valued at USD 3.74 billion in 2023, expected to reach USD 4.28 billion in 2024, and is projected to grow at a CAGR of 15.06%, to USD 9.99 billion by 2030.

Metabolomics, a comprehensive study of metabolites within a biological specimen, serves as a pivotal tool in understanding the intricate biochemical processes of living organisms. This field is critical for advancements in personalized medicine, disease biomarker discovery, and systems biology. Its application spans pharmaceuticals, biotechnology, agrigenomics, and food & beverages, among other sectors, making it an indispensable asset for innovation in health and nutrition. Key factors influencing the metabolomics market's growth include technological advancements in analytical techniques, increasing pharmaceutical and biotech R&D investments, and the rising prevalence of chronic diseases necessitating enhanced diagnostic methodologies. Recent technological innovations in mass spectrometry and nuclear magnetic resonance, coupled with advancements in bioinformatics, present significant opportunities for early disease detection and precision medicine development. However, challenges such as high costs of instruments and the need for skilled personnel may hinder market growth. There is also a notable requirement for standardization in methodologies and data interpretation to bridge the gap between complex data outputs and practical applications. Despite these concerns, regions like North America and Europe are leading metabolomics innovations due to supportive regulatory frameworks and substantial healthcare spending. To capitalize on this growing market, businesses should focus on expanding collaborative networks between academic institutions and industry players to spur technological development and knowledge exchange. Additionally, the development of cost-effective, high-throughput screening methods could transform metabolite analysis accessibility and application in various industries. Exploring novel areas such as microbiome metabolomics, plant metabolomics, and environmental metabolomics holds promise for new product development and diversification. The ever-evolving nature of the metabolomics market suggests a fertile ground for research and innovation, necessitating organizations to stay abreast of technological advancements and policy changes to optimize their strategy for sustained growth and competitive advantage.

KEY MARKET STATISTICS
Base Year [2023] USD 3.74 billion
Estimated Year [2024] USD 4.28 billion
Forecast Year [2030] USD 9.99 billion
CAGR (%) 15.06%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Metabolomics Market

The Metabolomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of cancer cases and need for advanced therapies
    • Ongoing adoption of personalized medicines
    • Favorable governmental initiatives associated with metabolomics research
  • Market Restraints
    • Concern regarding the complex data monitoring and data processing
  • Market Opportunities
    • Emergence of novel technologies along with market players for metabolomics
    • Rise of single-cell metabolomics
  • Market Challenges
    • Scarcity of skilled professionals in the healthcare sectors worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Metabolomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Metabolomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Metabolomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Metabolomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Metabolomics Market

A detailed market share analysis in the Metabolomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Metabolomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Metabolomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Metabolomics Market

A strategic analysis of the Metabolomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Metabolomics Market, highlighting leading vendors and their innovative profiles. These include Afekta Technologies Ltd., Bio-Rad Laboratories, Inc., Biocrates Life Science AG, Bruker Corporation, Danaher Corporation, General Electric Company, Hitachi High-Tech Corporation, Human Metabolome Technologies America Inc., Japan Spectroscopic Company, Kore Technology Limited, LECO Corporation, Merck KGaA, SCION Instruments UK Ltd, Shimadzu Corporation, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Metabolomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Bioinformatics Tools & Services and Metabolomics Instruments. The Bioinformatics Tools & Services is further studied across Bioinformatics Services and Bioinformatics Tools & Databases. The Metabolomics Instruments is further studied across Detection Tools and Separation Tools. The Detection Tools is further studied across Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy, and Surface-Based Mass Analysis. The Separation Tools is further studied across Capillary Electrophoresis, Gas Chromatography, High-performance Liquid Chromatography, and Ultra-performance Liquid Chromatography.
  • Based on Indication, market is studied across Cancer, Cardiovascular Disorders, Inborn Errors of Metabolism, Metabolic Disorders, and Neurological Disorders.
  • Based on Application, market is studied across Biomarker discovery, Drug discovery, Functional Genomics, Nutrigenomics, Personalized medicine, and Toxicology testing.
  • Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cancer cases and need for advanced therapies
      • 5.1.1.2. Ongoing adoption of personalized medicines
      • 5.1.1.3. Favorable governmental initiatives associated with metabolomics research
    • 5.1.2. Restraints
      • 5.1.2.1. Concern regarding the complex data monitoring and data processing
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of novel technologies along with market players for metabolomics
      • 5.1.3.2. Rise of single-cell metabolomics
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of skilled professionals in the healthcare sectors worldwide
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Metabolomics Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Bioinformatics Tools & Services
    • 6.2.1. Bioinformatics Services
    • 6.2.2. Bioinformatics Tools & Databases
  • 6.3. Metabolomics Instruments
    • 6.3.1. Detection Tools
      • 6.3.1.1. Mass Spectrometry
      • 6.3.1.2. Nuclear Magnetic Resonance Spectroscopy
      • 6.3.1.3. Surface-Based Mass Analysis
    • 6.3.2. Separation Tools
      • 6.3.2.1. Capillary Electrophoresis
      • 6.3.2.2. Gas Chromatography
      • 6.3.2.3. High-performance Liquid Chromatography
      • 6.3.2.4. Ultra-performance Liquid Chromatography

7. Metabolomics Market, by Indication

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Cardiovascular Disorders
  • 7.4. Inborn Errors of Metabolism
  • 7.5. Metabolic Disorders
  • 7.6. Neurological Disorders

8. Metabolomics Market, by Application

  • 8.1. Introduction
  • 8.2. Biomarker discovery
  • 8.3. Drug discovery
  • 8.4. Functional Genomics
  • 8.5. Nutrigenomics
  • 8.6. Personalized medicine
  • 8.7. Toxicology testing

9. Metabolomics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Metabolomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Metabolomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Metabolomics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Afekta Technologies Ltd.
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Biocrates Life Science AG
  • 4. Bruker Corporation
  • 5. Danaher Corporation
  • 6. General Electric Company
  • 7. Hitachi High-Tech Corporation
  • 8. Human Metabolome Technologies America Inc.
  • 9. Japan Spectroscopic Company
  • 10. Kore Technology Limited
  • 11. LECO Corporation
  • 12. Merck KGaA
  • 13. SCION Instruments UK Ltd
  • 14. Shimadzu Corporation
  • 15. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. METABOLOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. METABOLOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL METABOLOMICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL METABOLOMICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. METABOLOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. METABOLOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. METABOLOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL METABOLOMICS MARKET SIZE, BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL METABOLOMICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL METABOLOMICS MARKET SIZE, BY INBORN ERRORS OF METABOLISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL METABOLOMICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL METABOLOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 348. SWITZERLAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 355. TURKEY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 356. TURKEY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)

T